Stivarga is approved for use across multiple indications:
mCRC, GIST, and HCC1

Disease icon 1. Visit hcp.stivarga-us.com to see full safety and Prescribing Information, including Boxed Warning.

See the potential
in patients
previously treated
for metastatic
colorectal cancer (mCRC)

STIVARGA in mCRC
Disease icon 3. Visit hcp.stivarga-us.com to see full safety and Prescribing Information, including Boxed Warning.

Explore the 3rd-line
treatment of
gastrointestinal
stromal tumors (GIST)

STIVARGA in GIST
Disease icon 2. Visit hcp.stivarga-us.com to see full safety and Prescribing Information, including Boxed Warning.

Think one step ahead
for your hepatocellular
carcinoma (HCC)
patients previously treated with sorafenib

STIVARGA in HCC